Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/177709
Title: | Deep vein thrombosis in noncritically ill patients with coronavirus disease 2019 pneumonia: deep vein thrombosis in nonintensive care unit patients |
Author: | Jimenez Guiu, Xavier Huici Sánchez, Malka Romera Villegas, Antonio Izquierdo Miranda, Alexandre Sancho Cerro, Ana Vila Coll, Ramón |
Keywords: | COVID-19 Tromboflebitis COVID-19 Thrombophlebitis |
Issue Date: | 1-May-2021 |
Publisher: | Elsevier Inc. |
Abstract: | Background: Venous thromboembolic events have been one of the main causes of mortality among hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia. The aim of our study was to describe the prevalence of deep vein thrombosis (DVT) in noncritically ill patients with COVID-19 pneumonia and correlate such observations with the thromboprophylaxis received. Methods: We performed a prospective cohort study of 67 patients admitted to the hospital for COVID-19 pneumonia. The diagnosis was confirmed using polymerase chain reaction testing of nasopharyngeal specimens. The deep veins were examined using compression duplex ultrasonography with the transducer on B-mode. The patients were separated into two groups for statistical analysis: those receiving low-molecular-weight heparin prophylaxis and those receiving intermediate or complete anticoagulation treatment. Risk analysis and logistic regression were performed. Results: Of the 67 patients, 57 were included in the present study after applying the inclusion and exclusion criteria; 49.1% were women, and the patient mean age was 71.3 years. All 57 patients had undergone compression duplex ultrasonography. Of these 57 patients, 6 were diagnosed with DVT, for an in-hospital rate of DVT in patients with COVID-19 pneumonia of 10.5%. All the patients who had presented with DVT had been receiving low-molecular-weight heparin prophylaxis. The patients receiving prophylactic anticoagulation treatment had a greater risk of DVT (16.21%; 95% confidence interval, 0.04-0.28; P = .056) compared with those receiving intermediate or complete anticoagulation treatment. We also found a protective factor for DVT in the intermediate or complete anticoagulation treatment group (odds ratio, 0.19; 95% confidence interval, 0.08-0.46; P < .05). Conclusions: Noncritically ill, hospitalized patients with COVID-19 pneumonia have a high risk of DVT despite receipt of correct, standard thromboprophylaxis. |
Note: | Reproducció del document publicat a: https://doi.org/10.1016/j.jvsv.2020.08.028 |
It is part of: | Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2021, vol. 9, num. 3, p. 592-596 |
URI: | http://hdl.handle.net/2445/177709 |
Related resource: | https://doi.org/10.1016/j.jvsv.2020.08.028 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Deep vein thrombosis in noncritically ill patients with coronavirus.pdf | 179.19 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.